MabSolys is a private biotechnology company specialized in the field of antibodies R&D. Settled on the Biopark Genopole(R) (Evry, France), MabSolys benefits an ideal environment with privileged access to ISO-certified animal facilities of CERFE.
MABSOLUT / CRO Department
Through its dedicated CRO department “MAB’Solut” (www.mabsolut.com), MabSolys provides a large variety of customized and high added-value services for the innovative research projects of its partners and clients, as part of a comprehensive and complete offer:
- Design and optimization of the antigens,
- Antibodies creation and screening,
- Biochemical and immunological characterization,
- Production and purification,
- Customized engineering (binding optimization, fragments, chimerization, humanization, etc.),
- Tests development,
- In-vivo experiments (proof of concept, efficacy, pre-tox and pharmacokinetics studies).
More than 20 customers are working with MAB’Solut department.
On the other hand, the company is currently establishing its early-stage products pipeline, which will cover the field of monoclonal antibodies for therapeutics as well as diagnostics / theranostics / biomarkers uses, on the basis of innovative and specific targets.
Our expertise stems from 15 years of R&D for antibodies.
We perfectly master each step of the antibody development process, from antigen definition and preparation, up to in vitro tests and in vivo studies.
Genopole Campus 1
5 rue Henri Desbruères
91030, Evry Cedex